Delayed administration IL-1β neutralizing antibody improves cognitive function after transient global ischemia in...

Area of Science:

• Neuroscience
• Immunology
• Ischemic Stroke Research

Background:

• Global ischemia can lead to significant motor and cognitive deficits.
• Interleukin-1 beta (IL-1β) is implicated in the inflammatory response following ischemic events.
• The therapeutic window for intervention after ischemia is often limited.

Purpose of the Study:

• To investigate the neuroprotective effects of late inhibition of IL-1β on motor and cognitive functions after global ischemia.
• To determine if IL-1β antibody treatment 24 hours post-ischemia can mitigate neuronal damage.

Main Methods:

• Transient global ischemia was induced for 10 minutes in a rodent model.
• Intercerebroventricular injection of IL-1β antibody or vehicle was administered 24 hours after ischemia.
• Behavioral testing assessed motor and cognitive functions.
• Histological staining evaluated cell morphology and survival in the hippocampus.

Main Results:

• IL-1β antibody treatment 24 hours post-ischemia significantly improved cognitive function recovery.
• No significant amelioration in motor function was observed.
• Histological analysis confirmed that the IL-1β antibody reduced ischemia-induced neuronal morphological changes and cell loss in the hippocampus.

Conclusions:

• Inhibiting the IL-1β pathway 24 hours after global ischemia can be beneficial for cognitive function recovery.
• The protective effects are associated with reduced hippocampal cell loss.
• Targeting IL-1β represents a potential therapeutic strategy for post-ischemic cognitive impairment.